Financial Consulate’s Avanos Medical AVNS Stock Holding History

Financial Consulate’s Portfolio AVNS Stock Details AVNS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	–	Sell	-36	Closed	-$896	–	1902
2026 Q2	$896	Hold	36	–	–	﹤0.01%	1185
2026 Q1	$505	Hold	36	–	–	﹤0.01%	1262
2025 Q4	$405	Hold	36	–	–	﹤0.01%	1238
2025 Q3	$417	Buy	+36	New	+$422	﹤0.01%	1089

Other funds holding AVNS

IFP Advisors Tampa, Florida $5.86B AUM 20.09% 1-Year Est. Return

Financial Consulate's AVNS Position: Q3 2026 in Review

Financial Consulate sold out of Avanos Medical (AVNS) in Q3 2026, closing a stake of 36 shares — an estimated $896 sold.

Financial Consulate first reported a position in AVNS in Q3 2025 and held it in 4 quarters. The position peaked at $896 in Q2 2026. 1 fund tracked by Wall St. Rank holds AVNS as of Q3 2026.

Financial Consulate reported no remaining Avanos Medical position as of Q3 2026 after selling out during the quarter.
Financial Consulate sold 36 Avanos Medical shares in Q3 2026, an estimated $896.
Financial Consulate first reported a position in Avanos Medical in Q3 2025 and held it in 4 quarters.
Financial Consulate's Avanos Medical position peaked at $896 in Q2 2026.
1 fund tracked by Wall St. Rank held Avanos Medical as of Q3 2026.

Based on Financial Consulate's 13F filing for Q3 2026, filed 23 Oct 2026.